interferon alfa-2b ( intron a ; schering-plough ) was administered to 36 patients with chronic myeloid leukemia ( cml ) at an initial dose of 4 x 10 ( 6 ) iu/m2 daily subcutaneously , adapted to changes in leukocyte counts during the course of treatment .
C0021735
interferon alfa-2b
C0023473
chronic myeloid leukemia